ODC-IL2

· Trutino Biosciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ODC-IL2, covering 2025-01-13 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation and Expansion Study Evaluating ODC-IL2 in Adult Patients With Advanced or Metastatic Solid Tumors [Phase 1]

See pricing